Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cell Therapy
Sort By
Newest First
1 / 3
1 / 3
Cell Therapy
Facilitating Organoid Production for Biopharmaceutical Applications
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-12
Cell Therapy
Intelligent Cell Processing Enables Consistent, Reproducible, and Scalable GMP-Compliant Processes
Karen Weisinger, Ph.D.
Cell X Technologies
PAO-06-24-CL-07
May 30, 2024
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
Genezen
PR-M03-24-01-5831
March 06, 2024
Cell Therapy Manufacturing
Rethinking Cell Engineering for Cell Therapy Manufacturing
Todd Sulchek, Ph.D
CellFE
PAO-11-23-CL-03
December 13, 2023
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
CRB
PR-M10-23-05
October 19, 2023
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09
September 28, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04
September 05, 2023
Cord Blood Bank Alliance
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
Be The Match BioTherapies
PR-M07-23-01
July 13, 2023
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Denis Dufrane, M.D., Ph.D.
PAO-03-23-CL-06
March 20, 2023
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03
February 23, 2023
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-23-NI-01
January 31, 2023
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
Ryan Larson, Ph.D.
PAO-12-022-CL-04
January 03, 2023
Cell Therapy
Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-022-NI-08
November 15, 2022
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06
November 11, 2022
iPSCs
Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies
CCRM
PR-M11-22-04
November 07, 2022
Cell Therapy
Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making
Chris McClain
Be The Match BioTherapies
PAO-11-022-CL-01
November 01, 2022
Cell Therapy Manufacturing
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
AGC Biologics
PR-M08-22-03
August 16, 2022
Cord Blood
Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical Use
Be The Match BioTherapies
PR-M08-22-02
August 13, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03
August 09, 2022
Contamination Control
Contamination Control Strategies for the Manufacture of Conventional and Next-Generation Biologics
Chris Berridge; Rolf Hansen, Ph.D.; Donald Singer
Ecolab
PAO-07-022-CL-07
July 20, 2022